Effect of Epigallocatechin-3-Gallate Solution as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Necrotic Tooth

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05988788
Collaborator
(none)
42
2
12

Study Details

Study Description

Brief Summary

clinically compare the intensity of post-operative pain and the amount of bacterial load reduction after using 20% Epigallocatechin-3-gallate solution during chemomechanical preparation, versus 2.5% NaOCl, in asymptomatic necrotic mandibular premolars treated in a single visit.

Condition or Disease Intervention/Treatment Phase
  • Other: Epigallocatechin-3-gallate
  • Other: sodium hypochlorite
N/A

Detailed Description

The patients will be randomly divided into 2 groups. Intervention group (20% epigallocatechin-3-gallate solution root canal irrigant) and control group (2.5% sodium hypochlorite root canal irrigant).

Post-operative pain will be measured at 6, 12, 24 and 48 hours post-operatively. The pain will be recorded using the Numerical Rating Scale (NRS).

Amount of bacterial load reduction The intracanal bacterial load reduction will be determined using agar culture technique by counting the colony forming units per milliliter (CFUs/mL) before and after root canal preparation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Epigallocatechin-3-Gallate Solution Versus Sodium Hypochlorite as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Asymptomatic Necrotic Mandibular Premolars: A Randomized Clinical Trial
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Epigallocatechin-3-Gallate

20% Epigallocatechin-3-Gallate solution

Other: Epigallocatechin-3-gallate
to be used as a root canal irrigant
Other Names:
  • green tea catechin
  • Active Comparator: sodium hypochlorite

    2.5% sodium hypochlorite

    Other: sodium hypochlorite
    to be used as a root canal irrigant

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative pain [Postoperative pain measured at 6, 12, 24, 48 hours after single visit treatment.]

      Categorical None 0 Mild 1-3 Moderate 4-6 Severe 7-10

    Secondary Outcome Measures

    1. Amount of intracanal bacterial load reduction [T0: preintervention, preinstrumentation after access cavity. T1: postinstrumentation up to 10 min]

      The intracanal bacterial load reduction will be determined using agar culture technique by counting the colony forming units per milliliter (CFUs/mL) before and after root canal preparation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    The inclusion criteria:
    1. Systematically healthy patient (ASA I, II).

    2. Age between 18 and 45 years

    3. Male or female.

    4. Asymptomatic mandibular premolar teeth diagnosed with pulp necrosis.

    The exclusion criteria:
    1. Medically compromised patients having significant systemic disorders. (ASA III or IV).

    2. Teeth with:

    • Immature roots

    • Association with swelling or sinus tract.

    • Acute peri-apical abscess or acute exacerbation of a chronic abscess.

    • Mobility Grade II or III

    • Previously accessed or endodontically treated

    • Deep periodontal pockets more than 4 mm

    • Vertical root fractures, coronal perforation, calcification, and external or internal root resorptions.

    1. Patients who could not interpret the NRS.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: rayan adlan, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rayan Elsadig Izzeldin, Principal investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05988788
    Other Study ID Numbers:
    • Epigallocatechin-3-Gallate
    First Posted:
    Aug 14, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Rayan Elsadig Izzeldin, Principal investigator, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2023